Edition:
United Kingdom

People: Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,703.50GBp
14 Jun 2019
Change (% chg)

11.00 (+0.65%)
Prev Close
1,692.50
Open
1,692.50
Day's High
1,709.00
Day's Low
1,687.00
Volume
1,689,959
Avg. Vol
2,185,872
52-wk High
1,713.50
52-wk Low
1,242.50

Nawana, Namal 

Mr. Namal Nawana is Chief Executive Officer, Executive Director of the Company. He Joined the Board and was appointed Chief Executive Officer on 7 May 2018. He will stand for election by shareholders at the AGM on 11 April 2019. He is based in Andover, US. Career and experience Prior to Smith & Nephew Namal was Chief Executive Officer and a member of the Board of Medical Diagnostics Company Alere Inc, until its $8 billion acquisition by Abbott in 2017. Before joining Alere, Namal spent more than 15 years at Johnson & Johnson in progressively senior leadership roles globally including the role of Worldwide President of Johnson & Johnson’s multi-billion dollar spine franchise, DePuy Synthes Spine. In addition to his role as CEO of Smith & Nephew, Namal is also a member of the Board of Directors of Hologic, Inc. a Nasdaq listed company and Advamed (Advanced Medical Technology Association). Skills and competencies Namal holds an undergraduate degree in Mechanical Engineering and a Masters degree in Medical Science from the University of Adelaide, South Australia, as well as an MBA from Henley Management College. He is a global leader with broad experience in healthcare and medical technology.

Basic Compensation

Total Annual Compensation, USD 2,661,620
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 222,010
Fiscal Year Total, USD 2,883,630

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --